Abstract
We have found that DR6, a member of the TNF receptor family, is highly expressed in resting T cells and downregulated in activated T cells. DR6-targeted mutant mice were generated and showed normal development. However, DR6(-/-) CD4(+) T cells hyperproliferated in response to TCR-mediated stimulation and protein antigen challenge. Activated DR6(-/-) CD4(+) T cells exhibited upregulated CD25 expression and enhanced proliferation in response to exogenous IL-2 stimulation. In addition, increased CD28 and reduced CTLA-4 expression were observed in these cells. Enhanced Th2 cytokine production by activated DR6(-/-) CD4(+) T cells was associated with the increased transcription factor NF-ATc in nuclei. DR6, therefore, functions as a regulatory receptor for mediating CD4(+) T cell activation and maintaining proper immune responses.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Abatacept
-
Animals
-
Antigens, CD
-
Antigens, Differentiation / analysis
-
CD28 Antigens / analysis
-
CD4-Positive T-Lymphocytes / immunology*
-
CTLA-4 Antigen
-
Cytokines / biosynthesis*
-
DNA / metabolism
-
DNA-Binding Proteins / metabolism
-
Female
-
Immunoconjugates*
-
Lymphocyte Activation*
-
Mice
-
NFATC Transcription Factors
-
Nuclear Proteins*
-
Receptors, Interleukin-2 / analysis
-
Receptors, Tumor Necrosis Factor / genetics
-
Receptors, Tumor Necrosis Factor / physiology*
-
Transcription Factors / metabolism
Substances
-
Antigens, CD
-
Antigens, Differentiation
-
CD28 Antigens
-
CTLA-4 Antigen
-
Ctla4 protein, mouse
-
Cytokines
-
DNA-Binding Proteins
-
Immunoconjugates
-
NFATC Transcription Factors
-
Nuclear Proteins
-
Receptors, Interleukin-2
-
Receptors, Tumor Necrosis Factor
-
Tnfrsf21 protein, mouse
-
Transcription Factors
-
Abatacept
-
DNA